| NCT ID | NCT01757327 |
| Title | LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer |
| Recruitment | Withdrawn |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | yes |
| Sponsors | Washington University School of Medicine |
| Indications | |
| Therapies | |
| Age Groups: | adult |